Psychiatry — Dementia, NMC MBBS licence examination syllabus (Nepal Medical Council).
The first question is never "which dementia?" — it is "is this dementia at all?"
A 74-year-old is brought in by her daughter, who says she has become forgetful and muddled. That single sentence covers at least four very different situations: a progressive dementia, an acute delirium from an infection nobody has looked for, a depression that impairs concentration, or a hearing loss that has been mistaken for confusion.
Getting this wrong in either direction causes harm. Label a delirium as dementia and you miss a treatable illness happening today. Label a dementia as "just ageing" and the family loses the time they needed to plan.
This is the highest-yield discrimination in the whole topic, both for the exam and for the patient in front of you.
Three features separate them reliably:
Before accepting a progressive diagnosis, look for the contributors that can be corrected.
Depression deserves particular attention, because it is the great mimic. Depression in an older person often presents with poor concentration, slowed thinking and apathy — which the family describes as memory loss. The distinguishing feature is that a depressed patient often says "I don't know" and gives up, while a patient with dementia frequently confabulates and tries to cover the gap. Depression is treatable, so it must be actively considered, not assumed absent.
Then check the ordinary things: thyroid function, B12 deficiency, infection, alcohol, and above all the drug chart. Sedatives and anticholinergic drugs impair cognition in older people reliably, and are prescribed constantly. Deafness and poor vision are also mistaken for confusion far more often than anyone admits — a patient who cannot hear the question answers it wrongly.
Once a dementia is established, the subtype affects prognosis, management, and one very important prescribing decision.
AlzheimerThe commonest. Gradual onset, and early loss of memory for recent events while older memories persist. Decline is slow and fairly steady.
VascularClassically stepwise — a period of stability, then an abrupt drop, then stability again. Look for vascular risk factors and focal neurological signs.
Lewy bodyVisual hallucinations, cognition that fluctuates markedly, and parkinsonian features. Carries severe antipsychotic sensitivity — see below.
FrontotemporalYounger onset. Personality and social behaviour change first — disinhibition, apathy, loss of empathy — while memory is relatively spared early.
In practice, mixed pathology is common, particularly in the very old, where Alzheimer and vascular changes frequently coexist. A confident single label is often less honest than acknowledging the mixture.
If you remember one management point from this chapter, make it this one.
Patients with Lewy body dementia can react catastrophically to antipsychotic drugs — severe rigidity, collapse, and marked irreversible deterioration. This matters enormously in practice, because the situation in which someone reaches for an antipsychotic is precisely the situation Lewy body dementia produces: an older, confused patient with visual hallucinations.
So before any antipsychotic in an older confused patient, ask specifically about visual hallucinations, fluctuating cognition and parkinsonism. If those are present, seek specialist advice rather than prescribing. Doses, choices and monitoring for these drugs are specialist decisions and are not given here.And ask why the patient is distressed before treating the distress. Agitation in dementia usually has a reason: pain, urinary retention, constipation, hunger, fear, over-stimulation, or an unfamiliar environment. These are common, findable and correctable. Sedating a patient whose real problem is a full bladder treats the observer, not the patient.
Diagnose early and explain honestly. An early diagnosis gives the person time while they still have capacity — to settle their affairs, to say what treatment they would want later, and to nominate who should speak for them. That window closes, and it does not reopen.
Support the carer, because the carer is the treatment. Most people with dementia are looked after at home by a family member, usually with little support. Carer exhaustion is what ends home care more often than the illness itself. Asking the carer how they are managing is a clinical intervention, not a courtesy.
Simplify the environment and the drug chart. Routine, familiar surroundings, good lighting, working hearing aids and correct glasses all reduce confusion. Every sedating or anticholinergic drug should be justified again.
Drugs for cognition — cholinesterase inhibitors and memantine — help some patients modestly with symptoms. They do not halt the underlying disease, and expectations should be set accordingly. Choice, dose and monitoring are specialist matters.
A diagnosis of dementia does not remove the right to make decisions. Capacity is assessed for a particular decision at a particular time, and many people with dementia retain it for a great deal — where to live, what to eat, whether to accept a treatment — long after they have lost it for complex financial matters.
Fluctuation matters too: a patient may have capacity in the morning and not in the evening, or before and not during a delirium. The general framework for consent and capacity is covered in the ethics chapter; the point here is simply that the label is not the assessment.
Cognitive test cut-offs, drug choices and doses are deliberately not quoted here — screening instruments vary by version and require adjustment for education and language, and the drugs are specialist-initiated. Use your current local protocol.
Create a free account to tick topics off, take notes as you read, watch the video lessons and get a day-by-day study plan built around your exam date.
Loading…